Viewing nowCombinationOlmesartan Medoxomil/Amlodipine Besilate/Hydrochlorothiazide Tablet 10/40/12.5 mg
Amlodipine Besylate 13.888mg · Olmesartan Medoxomil 40mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.

MFDS item code 201805227 · Approved 2018.12.21 · Insurance code 644914620
Treatment of essential hypertension not controlled with concomitant amlodipine and olmesartan
This medication is an effective treatment for patients with essential hypertension whose blood pressure is not adequately controlled even with the combination therapy of amlodipine and olmesartan medoxomil. This medicine lowers blood pressure by dilating blood vessels and reducing the burden on the heart. It targets multiple mechanisms of action simultaneously through combination therapy, making it useful for situations where blood pressure control is difficult. Regular use can lead to stable management of blood pressure, reducing the risk of complications. Due to these characteristics, it is widely used for the treatment of essential hypertension.
Take 1 tablet once daily with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended to adjust the dose using the individual components (olmesartan medoxomil and amlodipine, as monotherapy or combination therapy). However, if blood pressure is not controlled with the combination of amlodipine and olmesartan medoxomil as described below, switching directly to this medicine may be considered. The maximum dose of this medicine is 10/40/25mg of amlodipine/olmesartan medoxomil/hydrochlorothiazide. As the maximum blood pressure-lowering effect occurs within 2 weeks of administration, adjust the dose at intervals of at least 2 weeks, taking the patient's blood pressure response into account. The recommended doses are as follows. - 5/20/12.5mg: For patients whose blood pressure is not adequately controlled with combination therapy of amlodipine/olmesartan medoxomil 5/20mg. - 5/40/12.5mg: For patients whose blood pressure is not adequately controlled with combination therapy of amlodipine/olmesartan medoxomil 5/40mg or with this medicine 5/20/12.5mg. - 5/40/25mg: For patients whose blood pressure is not adequately controlled with this medicine 5/40/12.5mg. - 10/40/12.5mg: For patients whose blood pressure is not adequately controlled with combination therapy of amlodipine/olmesartan medoxomil 10/40mg or with this medicine 5/40/12.5mg. - 10/40/25mg: For patients whose blood pressure is not adequately controlled with this medicine 5/40/25mg or this medicine 10/40/12.5mg. ※ Refer to the following dose-escalation schedule. (The amounts of the individual components are listed in the order amlodipine/olmesartan medoxomil/hydrochlorothiazide.) 5/20/0mg → 5/20/12.5mg ↓ 5/40/0mg → 5/40/12.5mg → 5/40/25mg ↓ ↓ 10/40/0mg → 10/40/12.5mg → 10/40/25mg Patients with renal impairment The maximum dose of this medicine for patients with mild to moderate renal impairment (creatinine clearance 30-60mL/min) is 20/5/12.5 milligrams once daily. Monitoring of potassium and creatinine levels is recommended in patients with moderate renal impairment. This medicine should not be administered to patients with severe renal impairment (creatinine clearance < 30mL/min). Patients with hepatic impairment Caution should be exercised when administering this medicine to patients with mild or moderate hepatic impairment. The maximum dose for patients with moderate hepatic impairment is 5/20/12.5 milligrams once daily. Blood pressure and renal function should be closely monitored in patients with hepatic impairment. This medicine should not be administered to patients with severe hepatic impairment. Older adults (65 years or older) Treatment is generally initiated at a low dose. When adjusting the dose, the patient's renal or cardiac function and comorbidities should be taken into account. Blood pressure should be monitored closely and more frequently in older adults. As experience with this medicine in older adults, particularly those aged 75 years or older, is very limited, patients should be monitored very carefully when receiving this medicine.
Safety and efficacy have not been established in pediatric patients under 18 years of age; use of this medicine is not recommended.
This medication can cause serious harm to the fetus and newborn in the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Do not use this medication if you are allergic to it or any of its components, or if you have certain heart and kidney diseases, hypotension, liver dysfunction, electrolyte abnormalities, etc. Patients with reduced blood volume or impaired kidney function may experience symptoms of hypotension at the beginning of treatment, so careful monitoring is necessary. This medication can affect kidney function, and patients with poor kidney function should undergo regular blood tests and electrolyte monitoring. Patients with liver or heart diseases should also be cautious when taking this medication, and particularly patients with liver cirrhosis should adjust the dose accordingly. This medication can cause skin hypersensitivity or photosensitivity, so care should be taken to avoid sun exposure, and if skin abnormalities occur, medical consultation should be sought immediately. Dizziness or drowsiness may occur while taking this medication, so it is advisable to avoid driving or operating hazardous machinery. This medication may interact with other blood pressure medications or specific drugs; therefore, if you are taking other medications, be sure to inform your physician or pharmacist. In case of overdose, severe hypotension or heart rhythm abnormalities may occur, necessitating immediate hospital treatment. The safety and effectiveness in children and adolescents under 18 years of age have not been established, hence its use is not recommended. Elderly patients may have reduced kidney and liver function; therefore, it is best to start at a lower dose and take it with caution. Store in a place out of reach of children and avoid moisture, heat, and direct sunlight.
Peripheral edema, headache, dizziness, upper respiratory infection, nasopharyngitis, urinary tract infection, sialadenitis, leukopenia, thrombocytopenia, bone marrow suppression, neutropenia, agranulocytosis, hemolytic anemia, aplastic anemia, anaphylactic reaction, drug hypersensitivity, hyperkalemia, hypokalemia, anorexia, diabetes, hypercalcemia, hyperglycemia, hypomagnesemia, hyponatremia, hypochloremia, hypertriglyceridemia, hypercholesterolemia, hyperuricemia, hypochloremic alkalosis, hyperamylasemia, confusion, depression, indifference, sensitivity to stimulation, anxiety, mood changes, sleep disorders, orthostatic dizziness, syncope, taste disturbance, hypertonicity, sensory loss, paresthesia, peripheral neuropathy, drowsiness, fainting, convulsions, loss of appetite, tremor, visual disturbances, reduced tears, worsening myopia, jaundice, dizziness, tinnitus, palpitations, tachycardia, myocardial infarction, arrhythmia, angina, hypotension, flushing, orthostatic hypotension, vasculitis, thrombosis, embolism, cough, bronchitis, shortness of breath, pharyngitis, rhinitis, acute interstitial pneumonia, respiratory distress syndrome, pulmonary edema, diarrhea, nausea, constipation, dry mouth, abdominal pain, change in bowel habits, bloating, dyspepsia, gastritis, stomach discomfort, gastroenteritis, gingival hyperplasia, paralytic ileus, pancreatitis, vomiting, hepatitis, jaundice, acute cholecystitis, autoimmune hepatitis, hair loss, angioedema, allergic dermatitis, erythema multiforme, erythema, lupus erythematosus-like reaction, pustular rash, exfoliative dermatitis, hyperhidrosis, photop sensitivity, pruritus, purpura, Quincke's edema, rash, recurrence of lupus erythematosus, toxic skin necrosis, skin discoloration, Stevens-Johnson syndrome, urticaria, muscle cramps, joint swelling, muscle weakness, ankle swelling, arthralgia, arthritis, low back pain, paresis, myalgia, bone pain, frequent urination, acute renal failure, hematuria, urination disorders, nocturia, interstitial nephritis, renal failure, erectile dysfunction, gynecomastia, asthenia, fatigue, chest pain, fever, influenza-like symptoms, lethargy, malaise, edema, pain, facial edema, elevated serum creatinine, elevated blood urea, elevated serum uric acid, decreased serum potassium, elevated gamma-glutamyl transferase, elevated alanine aminotransferase, elevated aspartate aminotransferase, elevated liver enzymes, elevated serum creatine phosphokinase, weight loss, weight gain, rhabdomyolysis, chronic malabsorption syndrome, intestinal vasogenic edema, altered consciousness, drug hypersensitivity, epigastric pain, decreased libido, scrotal edema, asthenia, eczema, limb pain, mild decrease in average hemoglobin and hematocrit levels, chronic malabsorption syndrome-like intestinal disease, acute respiratory distress syndrome, hypotension, palpitations, bradycardia, non-cardiogenic pulmonary edema, nausea, somnolence
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air or moisture, preferably at room temperature between 1 and 30 degrees Celsius. Proper storage will maintain the medication's efficacy and safety.
Red-brown round film-coated tablets
28 tablets (14 tablets/PTP X 2)/carton
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 13.888mg · Olmesartan Medoxomil 40mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg +1 more
Tablet · Prescription medication · Combination
Hanmi Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 13.888mg +1 more
Tablet · Prescription medication · Combination
Daicel Corporation (Co., Ltd.)
CombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg +1 more
Tablet · Prescription medication · Combination
HanKook Daiichi Sankyo Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 20mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Corporation
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.